Dog · Canis lupus familiaris · typical adult weight 2.00–80.00 kg
Lokivetmab Injectable is dosed at 2 mg/kg SC q4-8 weeks in dogs, per Plumb's Veterinary Drug Handbook, 10th ed (2023, held copy; the original seed cited the 9th, which was never consulted) — Lokivetmab, Dosages: DOGS, label dosage (corpus p.799); 1 mg/kg lower bound from the extra-label entry on corpus p.800 — SOURCE EDITION: Plumb's Veterinary Drug Handbook — ISBN 9781394172207, https://openlibrary.org/isbn/9781394172207. Lokivetmab Injectable is used in dogs for Atopic dermatitis (pruritus control), Atopic dermatitis. Routes documented in dogs: SC. A typical adult dog weighs 2.00–80.00 kg. ExoticRx lists 2 cited dose rules for Lokivetmab Injectable in dogs, drawn from published veterinary references. Verify against current literature before clinical use.
US trade names: Cytopoint Injectable, Cytopoint
| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| SC | 2 mg/kg | q4-8 weeks | Long-term; repeat when pruritus returns | Atopic dermatitis (pruritus control) | Strong | Plumb's Veterinary Drug Handbook, 10th ed (2023, held copy; the original seed cited the 9th, which was never consulted) — Lokivetmab, Dosages: DOGS, label dosage (corpus p.799); 1 mg/kg lower bound from the extra-label entry on corpus p.800 — SOURCE EDITION: Plumb's Veterinary Drug Handbook — ISBN 9781394172207, https://openlibrary.org/isbn/9781394172207 |
| SC | 1–2 mg/kg | q4-8 weeks | Long-term | Atopic dermatitis | Strong | Plumb's Veterinary Drug Handbook, 10th ed (2023, held copy; the original seed cited the 9th, which was never consulted) — Lokivetmab, Dosages: DOGS, label dosage (corpus p.799); 1 mg/kg lower bound from the extra-label entry on corpus p.800 — SOURCE EDITION: Plumb's Veterinary Drug Handbook — ISBN 9781394172207, https://openlibrary.org/isbn/9781394172207 |
Every held source for this drug and species, as printed. Where they differ, both are shown — the choice is yours, not ours.
| Dose (mg/kg) | Route | Source | As printed |
|---|---|---|---|
| 1 | SC | BSAVA Small Animal Formulary, 10th ed — Part A (Canine and Feline)p.250 | 1 mg/kg s.c. monthly |
Figures are transcribed from the cited page or table of each held edition and are shown for reference only. They are not dose recommendations, they do not feed the calculator, and none has been reviewed by a veterinarian.
Need the exact dose for your patient?
These ranges are per kg. Enter your dog's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
Caninized monoclonal antibody targeting interleukin-31 (IL-31), a key pruritogenic cytokine. Neutralizes IL-31 before it can bind to its receptor on sensory neurons.
Dogs only (species-specific). Vomiting may occur post-injection. Avoid in breeding/pregnant/lactating dogs. Efficacy lasts ~4-8 weeks. No known drug interactions.
Species-specific contraindications and adverse-reaction reports for dogs may differ from canine / feline reference data — consult the primary citations listed with each rule.
Lokivetmab Injectable dose ranges in dogs, with cited source references: SC 2 mg/kg q4-8 weeks; SC 1–2 mg/kg q4-8 weeks. Reference ranges from cited sources — verify against current literature before clinical use.
Documented routes for Lokivetmab Injectable in dogs: SC.
Cited course lengths for Lokivetmab Injectable in dogs include: Long-term; repeat when pruritus returns; Long-term. Duration depends on the indication — match it to the specific dose rule in the table above.
Lokivetmab Injectable is indicated in dogs for: Atopic dermatitis (pruritus control), Atopic dermatitis.
These are general warnings for Lokivetmab Injectable across species; consult the dog dosing table above for species-specific guidance. Dogs only (species-specific). Vomiting may occur post-injection. Avoid in breeding/pregnant/lactating dogs. Efficacy lasts ~4-8 weeks. No known drug interactions.
Why a species-specific page? Lokivetmab Injectable pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in dogs — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.